John Lukens

Dr. John Lukens

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2018 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
ALAntoine Louveau
Antoine Louveau
JHJasmin Herz
Jasmin Herz
MAMaria Nordheim Alme
Maria Nordheim Alme
ASAndrea Francesca Salvador
Andrea Francesca Salvador
MDMichael Q. Dong
Michael Q. Dong
JKJonathan Kipnis
Jonathan Kipnis

1 July 2012 in Nature
Verified
Journal Article
Open access
PDF file
PAParas Anand
Paras Anand
MKMalireddi R. K.Subbarao
Malireddi R. K.Subbarao
JLJohn Lukens
John Lukens
PVPeter Vogel
Peter Vogel
JBJohn Bertin
John Bertin
Thirumala-Devi KannegantiThirumala-Devi Kanneganti
Thirumala-Devi Kanneganti
The Nod-like receptor family member NLRP6 is characterized and shown to be a negative regulator of inflammatory signalling, dampening host responses against bacterial infections and impeding bacterial clearance. Previous studies have shown that the NOD-like receptors (NLRs) NOD1, NOD2, NLRC4 and NLRP3 respond to pathogens and microbial ligands by initiating signalling pathways that help to clear the infectious agent. The role of another member of the NLR family, NLRP6, has been unclear. Here, NLRP6 is shown to have a rather different role, dampening inflammatory signalling and thereby promoting bacterial dissemination and systemic colonization during infection. This suggests that therapeutic inhibition of NLRP6 activation may prove beneficial for treating infectious diseases. Members of the intracellular nucleotide-binding and oligomerization domain (NOD)-like receptor (NLR) family contribute to immune responses through activation of nuclear factor-κB (NF-κB), type I interferon and inflammasome signalling1. Mice lacking the NLR family member NLRP6 were recently shown to be susceptible to colitis and colorectal tumorigenesis2,3,4, but the role of NLRP6 in microbial infections and the nature of the inflammatory signalling pathways regulated by NLRP6 remain unclear. Here we show that Nlrp6-deficient mice are highly resistant to infection with the bacterial pathogens Listeria monocytogenes, Salmonella typhimurium and Escherichia coli. Infected Nlrp6-deficient mice had increased numbers of monocytes and neutrophils in circulation, and NLRP6 signalling in both haematopoietic and radioresistant cells contributed to increased susceptibility. Nlrp6 deficiency enhanced activation of mitogen-activated protein kinase (MAPK) and the canonical NF-κB pathway after Toll-like receptor ligation, but not cytosolic NOD1/2 ligation, in vitro. Consequently, infected Nlrp6-deficient cells produced increased levels of NF-κB- and MAPK-dependent cytokines and chemokines. Thus, our results reveal NLRP6 as a negative regulator of inflammatory signalling, and demonstrate a role for this NLR in impeding clearance of both Gram-positive and -negative bacterial pathogens.

1 March 2015 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
Prajwal GurungPrajwal Gurung
Prajwal Gurung
JLJohn Lukens
John Lukens
Thirumala-Devi KannegantiThirumala-Devi Kanneganti
Thirumala-Devi Kanneganti

10 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAshley C. Bolte
Ashley C. Bolte
ADArun B. Dutta
Arun B. Dutta
MHMariah E. Hurt
Mariah E. Hurt
ISIgor Smirnov
Igor Smirnov
MKMichael A. Kovacs
Michael A. Kovacs
JLJohn Lukens
John Lukens
Traumatic brain injury (TBI) is a leading global cause of death and disability. Here we demonstrate in an experimental mouse model of TBI that mild forms of brain trauma cause severe deficits in meningeal lymphatic drainage that begin within hours and last out to at least one month post-injury. To investigate a mechanism underlying impaired lymphatic function in TBI, we examined how increased intracranial pressure (ICP) influences the meningeal lymphatics. We demonstrate that increased ICP can contribute to meningeal lymphatic dysfunction. Moreover, we show that pre-existing lymphatic dysfunction before TBI leads to increased neuroinflammation and negative cognitive outcomes. Finally, we report that rejuvenation of meningeal lymphatic drainage function in aged mice can ameliorate TBI-induced gliosis. These findings provide insights into both the causes and consequences of meningeal lymphatic dysfunction in TBI and suggest that therapeutics targeting the meningeal lymphatic system may offer strategies to treat TBI.

1 July 2015 in Neuron
Verified
Journal Article
Closed access
SGSachin P. Gadani
Sachin P. Gadani
JWJames T. Walsh
James T. Walsh
JLJohn Lukens
John Lukens
JKJonathan Kipnis
Jonathan Kipnis

17 October 2022 in Cell
Verified
Journal Article
Open access
HEHannah Ennerfelt
Hannah Ennerfelt
EFElizabeth L. Frost
Elizabeth L. Frost
DSDaniel A. Shapiro
Daniel A. Shapiro
CHCoco Holliday
Coco Holliday
KZKristine E. Zengeler
Kristine E. Zengeler
JLJohn Lukens
John Lukens
Recent studies have begun to reveal critical roles for the brain’s professional phagocytes, microglia, and their receptors in the control of neurotoxic amyloid beta (Aβ) and myelin debris accumulation in neurodegenerative disease. However, the critical intracellular molecules that orchestrate neuroprotective functions of microglia remain poorly understood. In our studies, we find that targeted deletion of SYK in microglia leads to exacerbated Aβ deposition, aggravated neuropathology, and cognitive defects in the 5xFAD mouse model of Alzheimer’s disease (AD). Disruption of SYK signaling in this AD model was further shown to impede the development of disease-associated microglia (DAM), alter AKT/GSK3β-signaling, and restrict Aβ phagocytosis by microglia. Conversely, receptor-mediated activation of SYK limits Aβ load. We also found that SYK critically regulates microglial phagocytosis and DAM acquisition in demyelinating disease. Collectively, these results broaden our understanding of the key innate immune signaling molecules that instruct beneficial microglial functions in response to neurotoxic material.